Ironshore Pharmaceuticals And Development, Inc

This study tested a long-acting form of methylphenidate (Ritalin) given in the evening to children aged 4-5 with ADHD. The goal was to see if it improved ADHD symptoms and was safe. However, the trial was stopped early and only enrolled 26 children, so we cannot draw firm conclus…